GlassScriptPhysician profile
Jamie Baylor
NPI 1245015445
$634.37
in general payments reported to CMS, 2019-2025
8 companies · $554 in 2025
The $554 reported for 2025 was more than what 76% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $79.95 · 2025: $554.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $564 · Education: $69.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $564.38 |
| Education | $69.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $218.80 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $166.03 | 2025 | Airsupra, Tezspire, Fasenra |
| Sanofi-Aventis U.S. LLC | $69.99 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $50.81 | 2024-2025 | Dupixent |
| Novartis Pharmaceuticals Corporation | $48.74 | 2025 | |
| Glaxosmithkline, LLC. | $38.24 | 2025 | Nucala |
| Takeda Pharmaceuticals U.S.A., INC. | $33.53 | 2025 | Eohilia |
| Organon LLC | $8.23 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Baylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.